Table 1.
Effect of date palm pollen ethanolic extract (500 mg/kg bw/day) and/or doxorubicin (2.5 mg/kg bw/day) on body, heart, and relative heart weights myocyte cross-sectional area of control and treated rats.
| Groups | Initial Body Weight (g) | Body Weight (g) | Heart Weight (g) | RHW (%) | Cardiomyocyte Cross-Sectional Area (μm2) |
|---|---|---|---|---|---|
| CTR | 194 ± 4.5 | 218.43 ± 4.86 | 0.85 ± 0.013 | 0.52 ± 0.07 | 138.03 ± 3.90 |
| DPPE | 195 ± 5.2 | 221.85 ± 6.51 | 0.87 ± 0.023 | 0.49 ± 0.06 | 135.40 ± 2.65 |
| DOX | 190 ± 8.1 | 189.14 ± 8.36 * | 1.36 ± 0.047 * | 0.88 ± 0.11 * | 210.87 ± 5.26 * |
| DOX + DPPE | 192 ± 3.6 | 204.43 ± 2.72 | 1.04 ± 0.061 † | 0.63 ± 0.09 | 154.94 ± 2.06 † |
Control (CTR); date palm pollen ethanolic extract (DPPE); doxorubicin-treated (DOX); doxorubicin and date palm pollen ethanolic extract-treated (DOX + DPPE) groups, and relative heart weight (RHW). (n = 7). Each value is the average of 7 observations. Values are mean ± standard error (SEM). Mean values within the same columns were statistically different from CTR and DPPE (* p < 0.05). CTR, DPPE and DOX († p < 0.05).